Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Neonc Technologies, Inc.
Stemline Therapeutics, Inc.
Australian & New Zealand Children's Haematology/Oncology Group
Blueprint Medicines Corporation
Eli Lilly and Company
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Nationwide Children's Hospital
Institut Curie
Cedars-Sinai Medical Center
Binhui Biopharmaceutical Co., Ltd.
In8bio Inc.
Regeneron Pharmaceuticals